Bonell Patiño-Escobar, MD

Title(s)Postdoctoral Scholar, Laboratory Medicine
SchoolSchool of Medicine
Address185 Berry Street Bldg B, #2410
San Francisco CA 94158
Phone415-514-6238
Emailorlando.patinoescobar@ucsf.edu
ORCID ORCID Icon0000-0003-2622-4822 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Fundacion Universitaria Juan N. Corpas, Bogota - ColombiaMD2009
    Hospital Universitario Clinica San Rafael, Bogota - ColombiaResidency2014Internal Medicine
    Hospital de San José, Bogota ColombiaFellowship2016Hematology
    Collapse Awards and Honors
    Multiple Myeloma Research Foundation2022  - 20252022 MMRF Research Fellowship

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma. Clin Cancer Res. 2024 03 01; 30(5):1009-1021. Wadhwa A, Wang S, Patiño-Escobar B, Bidkar AP, Bobba KN, Chan E, Meher N, Bidlingmaier S, Su Y, Dhrona S, Geng H, Sarin V, VanBrocklin HF, Wilson DM, He J, Zhang L, Steri V, Wong SW, Martin TG, Seo Y, Liu B, Wiita AP, Flavell RR. PMID: 38109209; PMCID: PMC10905524.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    2. Structural surfaceomics reveals an AML-specific conformation of integrin β2 as a CAR T cellular therapy target. Nat Cancer. 2023 Nov; 4(11):1592-1609. Mandal K, Wicaksono G, Yu C, Adams JJ, Hoopmann MR, Temple WC, Izgutdina A, Escobar BP, Gorelik M, Ihling CH, Nix MA, Naik A, Xie WH, Hübner J, Rollins LA, Reid SM, Ramos E, Kasap C, Steri V, Serrano JAC, Salangsang F, Phojanakong P, McMillan M, Gavallos V, Leavitt AD, Logan AC, Rooney CM, Eyquem J, Sinz A, Huang BJ, Stieglitz E, Smith CC, Moritz RL, Sidhu SS, Huang L, Wiita AP. PMID: 37904046; PMCID: PMC10663162.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    3. Overcoming proteasome inhibitor resistance in the immunotherapy era. Trends Pharmacol Sci. 2023 08; 44(8):507-518. Patiño-Escobar B, Talbot A, Wiita AP. PMID: 37344251.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    4. Unraveling the surface proteomic profile of multiple myeloma to reveal new immunotherapeutic targets and markers of drug resistance. Cell Stress. 2022 Nov; 6(11):89-92. Patiño-Escobar B, Ferguson ID, Wiita AP. PMID: 36311892; PMCID: PMC9558132.
      View in: PubMed   Mentions: 2  
    5. Allosteric HSP70 inhibitors perturb mitochondrial proteostasis and overcome proteasome inhibitor resistance in multiple myeloma. Cell Chem Biol. 2022 08 18; 29(8):1288-1302.e7. Ferguson ID, Lin YT, Lam C, Shao H, Tharp KM, Hale M, Kasap C, Mariano MC, Kishishita A, Patiño Escobar B, Mandal K, Steri V, Wang D, Phojanakong P, Tuomivaara ST, Hann B, Driessen C, Van Ness B, Gestwicki JE, Wiita AP. PMID: 35853457; PMCID: PMC9434701.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    6. The surfaceome of multiple myeloma cells suggests potential immunotherapeutic strategies and protein markers of drug resistance. Nat Commun. 2022 07 15; 13(1):4121. Ferguson ID, Patiño-Escobar B, Tuomivaara ST, Lin YT, Nix MA, Leung KK, Kasap C, Ramos E, Nieves Vasquez W, Talbot A, Hale M, Naik A, Kishishita A, Choudhry P, Lopez-Girona A, Miao W, Wong SW, Wolf JL, Martin TG, Shah N, Vandenberg S, Prakash S, Besse L, Driessen C, Posey AD, Mullins RD, Eyquem J, Wells JA, Wiita AP. PMID: 35840578; PMCID: PMC9287322.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    7. FcεRIγ-negative NK cells persist in vivo and enhance efficacy of therapeutic monoclonal antibodies in multiple myeloma. Blood Adv. 2021 08 10; 5(15):3021-3031. Bigley AB, Spade S, Agha NH, Biswas S, Tang S, Malik MH, Dai L, Masoumi S, Patiño-Escobar B, Hale M, DiPierro G, Martell R, Hann B, Shah N, Wiita AP, Liu X. PMID: 34357379; PMCID: PMC8361460.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    8. CD38: From Positive to Negative Expression after Daratumumab Treatment. Cureus. 2020 Apr 10; 12(4):e7627. Patiño-Escobar B, Ramos R, Linares M, Mejía A, Alcalá S. PMID: 32399359; PMCID: PMC7213648.
      View in: PubMed   Mentions: 2  
    9. Niemann-Pick Disease: An Approach for Diagnosis in Adulthood. Cureus. 2019 May 28; 11(5):e4767. Patiño-Escobar B, Solano MH, Zarabanda L, Casas CP, Castro C. PMID: 31363448; PMCID: PMC6663041.
      View in: PubMed   Mentions: 3  
    10. Myelomastocytic Blast Cell Crisis in Resistant Tyrosine Kinase Inhibitor Chronic Myelogenous Leukemia: Case Report and Review of Literature. Cureus. 2019 May 21; 11(5):e4703. Martinez-Cordero H, Patiño-Escobar B, Enciso LJ, Otero DM, Spirko P. PMID: 31223555; PMCID: PMC6561613.
      View in: PubMed   Mentions: 1  
    Bonell's Networks
    Concepts (33)
    Derived automatically from this person's publications.
    _
    Co-Authors (30)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _